highlight
guidanc in-lin prior commentari ms/con
expect increment detail primari care strategi
showcas path profit ber wrinkl
quarter issu contain less mix up
estim pt
guidanc in-lin outlook provid back
octob new detail call includ revis hif impact estim
prior estim reinvest out-performance
benefit headwind corpor cost margin
in-lin last year level model individu margin
translat retail contribut versu
manag expect midpoint earn cadenc impli
ep annual ep versu ms con
perform ber outlook impact client migrat level
fund aso product on-going headwind group segment ber group
/commerci ber bp higher impli upper end
guidanc rang bp bp ms/con mainli driven mix shift
level fund aso product integr stop loss coverag context
level fund product fix level monthli premium stop
loss integr mean claim less fund amount client
get refund claim fund amount pay
overal type plan limit client financi exposur unforeseen
cost exhibit see tradit fulli insur premium differ
level fund premium plan hand enrol continu
strong perform membership y/i sequenti
ahead ms estim y/i flat sequenti manag
continu expect growth y/i in-lin market growth
individu y/i growth group membership
primari care primari focu matter scale question call
focus primari care strategi clinic model econom new partnership
welsh carson initi target new center three year
healthcar facil manag unit state
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
period seem conserv us discuss call highlight measur
approach reflect complex brick mortar model
popul util exist clinic infrastructur goal doubl util
member translat near term benefit medic cost
compani move member valu base agreement translat
improv score lower loss ratio manag plan
ad center add bring total center
clinic econom commentari suggest clinic run ebitda loss
first two year grow million annual ebitda contribut
depend size clinic locat
improv pdp outlook manag expect membership
loss versu prior expect new
valu rx lowest premium across largest market compet
gain traction offset expect eros premier rx plan
highest premium three humana pdp plan reflect chang
plan design combin prior wal-mart rx enhanc rx plan context
total pdp enrol first month year
deep dive pdp landscap detail
updat model estim reflect guidanc price target
base increment color provid today earn call
updat estim model ep
vs consensu
ep estim in-lin midpoint guidanc exhibit
earn bridg
exhibit humana ep bridg
ep tailwind
corpor cost
growth flat margin y/i medicaid growth guidanc
price increas infrastructur invest drive core perform guidanc
incom minor interest kindr hospic busi provid guidanc
share repurchas guidanc
hif come back headwind guidanc
retail out-performance reinvest benefit guidanc
corpor cost guidanc
bear bull midpoint
compar ms/con
compar manag guidanc
compani data estim
calcul price target appli price-to-earnings multipl base case ep
normal hif multipl reect premium multipl
 histor trade premium average adjust
multipl recent repeal hif estimate
high earn exposur
medicar advantag
execut organ medicaid
growth earn
medicaid provid addit growth
pipelin copmani
recent medicaid contract win la
ky underscor manag medicaid
strategi play
strong balanc sheet continu
solid cash gener lay foundat
view descript risk reward theme
thomson reuter morgan stanley research morgan stanley institut equiti divis probabl
bull base bear case scenario play estim impli volatil data option market
feb gure approxim risk-neutr probabl stock reach beyond scenario price
either three-month one-year time view explan option probabl methodolog
ep plu hif
bull case multipl reect premium
bull case multipl reect premium
multipl
multipl in-lin
premium peak
compani see strong
quarterli result get
benet tax reform adj hif repeal
increas share vertic
leverag vertic servic pbm
home health fuel margin expans
better outcom integr model
translat improv score share
ep plu hif
base case multipl reect premium
base case multipl reect premium
multipl
multipl
histor trade premium
average adjust multipl
recent repeal hif estimate
less busi exposur
commerci medicaid market segment
compar peer
sensit overal economi growth
continu outpac market result
ep plu hif adj
bear case multipl reect discount
bear case multipl reect discount
current multipl
current multipl
in-lin discount
trough last price
qualiti issu adj hif repeal
unabl maintain posit
medicar advantag group
focus grow busi
challeng price benet design
margin fail reach target
 strateg ventur leverag footprint
enhanc valu base offer
view explan region hierarchi
research highest favor quintil
abl grow medicaid busi
rfp win tuck-in
compani abl sustain market
margin improv target rang
unabl maintain recent
improv star rate
competit medicar advantag
make growth challeng
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
servic aso
depreci amort
invest incom
incom tax
incom continu oper
adjust incom continu op
tax rate hif
servic aso
